SureSelect Cancer All-In-One Lung Assay
The Agilent SureSelect Cancer All-In-One lung assay is a targeted NGS assay that analyzes a lung cancer panel of 20 genes relevant to NSCLC. Starting from 50 ng of DNA, four types of genomic variants, including SNVs, indels, CNVs, and translocations, are detected. This streamlined profiling of NSCLC also supports FFPE samples.
The target genes were selected to cover all genomic biomarkers in NSCLC, including the somatic variants associated with NSCLC in the guidelines of the National Comprehensive Cancer Network (NCCN), the College of American Pathologists (CAP), and the European Society for Medical Oncology (ESMO).
For Research Use Only. Not for use in diagnostic procedures.